TrialEuropean journal of drug metabolism and pharmacokinetics2022
Pharmacokinetics, Tolerability, Safety, and Immunogenicity of LY01008 and Bevacizumab (Avastin®) in Healthy Chinese Subjects.
Lijun Xie et al.PubMed ↗Publisher ↗
No numbers read from the abstract.